YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Genentech, Roche’s Rituxan Drug Curbs Leukemia


December 11, 2008 | Clinical trials show that Rituxan combined with chemotherapy slowed chronic lymphatic leukemia. Patients had a 41% reduction in the risk of death or their cancer progressing when compared with those treated with chemotherapy alone. Bloomberg 

View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.